Showing results (51-60 of 93) with videos related to
Sort By:
Pageof 10
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 20, 2026
Diagnostic Yield of Repeat Blood Cultures and Risk Factors for Bloodstream Infection in Persistent Febrile NeutropeniaEmily A Rosen, Elizabeth M Krantz, Allison Thibodeau, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donorsTerry Furlong, Hans-Peter Kiem, Frederick R Appelbaum, et al.Journal of Clinical Immunology|May 10, 2002
Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectivesMarco Mielcarek, Brenda M Sandmaier, David G Maloney, et al.Leukemia|January 25, 2020
Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AMLLinde M Morsink, Megan Othus, Evandro D Bezerra, et al.Transplantation|March 30, 2006
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantationLauri Burroughs, Marco Mielcarek, Wendy Leisenring, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioningFrédéric Baron, Michael B Maris, Brenda M Sandmaier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioningChristopher G Kanakry, Paul V O'Donnell, Terry Furlong, et al.Bone Marrow Transplantation|January 31, 2022
Outcomes after hematopoietic cell transplantation among non-English- compared to English-speaking recipientsAhona Mukherjee, Ted Gooley, Marco Mielcarek, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantationMarcello Rotta, Barry E Storer, Rainer Storb, et al.Blood Advances|January 4, 2018
Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myelomaDamian J Green, David G Maloney, Barry E Storer, et al.Pageof 10